Author

Chris van Lieshout

CONTINUATION OF ANTI-TNF IN PATIENTS WITH ULCERATIVE COLITIS IN REMISSION IS NOT COST-EFFECTIVE COMPARED TO TREATMENT WITHDRAWAL: A MARKOV MODEL
CONTINUATION OF ANTI-TNF IN PATIENTS WITH ULCERATIVE COLITIS IN REMISSION IS NOT COST-EFFECTIVE COMPARED TO TREATMENT WITHDRAWAL: A MARKOV MODEL

Chris van Lieshout  et al.

Item 1 - 1 / 1
1